Clinical Trial Update: Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma [Phase 4]

View source ↗

Summary

Clinical trial update describing a Phase 4 study of standalone iStent Infinite and iDose TR for moderate-to-severe open-angle glaucoma, with recruitment current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma
• Pigmentary Glaucoma
• Pseudoexfoliation Glaucoma

Drugs mentioned

• IDOSE TR (travoprost intracameral)
• iStent Infinite

Snippet

Sponsor: Jonathon Myers | Conditions: Open Angle Glaucoma, Pigmentary Glaucoma | Phase 4 | Status: RECRUITING